Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference
18 October 2022 - 09:50PM
Eton Pharmaceuticals (“Eton” or “the Company”) (Nasdaq: ETON), an
innovative pharmaceutical company focused on developing and
commercializing treatments for rare diseases, today announced that
Sean Brynjelsen, Chief Executive Officer, will present at the LD
Micro Main Event XV Conference as follows:
Date: |
Wednesday, October 26, 2022 |
Time: |
6:00PM ET |
Register to watch the event
here: |
Click Here |
|
|
The webcast will be accessible via the Company’s website at
https://ir.etonpharma.com/ in the Investors section under Events
and Presentations.
Eton will be participating in 1x1 meetings, which can be
requested through your LD Micro representative.
About Eton PharmaceuticalsEton Pharmaceuticals,
Inc. is an innovative pharmaceutical company focused on developing,
acquiring, and commercializing treatments for rare diseases. The
Company currently commercializes ALKINDI SPRINKLE® and Carglumic
Acid tablets and has four additional rare disease products under
development, including dehydrated alcohol injection and the ZENEO®
hydrocortisone autoinjector. For more information, please visit our
website at www.etonpharma.com.
Investor Relations:Lisa M. Wilson, In-Site
Communications, Inc.T: 212-452-2793E:
lwilson@insitecony.com
Source: Eton Pharmaceuticals
Eton Pharmaceuticals (NASDAQ:ETON)
Historical Stock Chart
From Feb 2024 to Mar 2024
Eton Pharmaceuticals (NASDAQ:ETON)
Historical Stock Chart
From Mar 2023 to Mar 2024